The interactions of cells with their neighbors and with the extracetlular matrix play crucial roles in development and in numerous physiological and pathological processes (Hay 1991; Hynes and Lander 1992) . Studies of cell adhesion during the past decade and more have uncovered the existence of a large number of cell adhesion molecules. These include cellsurface receptors involved in cell-cell adhesion, such as the cadherins (Takeichi 1988 (Takeichi , 1990 (Takeichi , 1991 , members of the immunoglobulin superfamily (Jessell 1988; Grumet 1991) , and selectins (Bevilacqua et al. 1991; Lasky and Rosen 1992) . Each of these families of receptors includes multiple related molecules. The same is true for cell-matrix adhesion, which is most frequently mediated by the family of adhesion receptors known as integrins (Hynes 1987 (Hynes , 1992 Albelda and Buck 1990; Hemler 1990) .
Integrins are heterodimeric transmembrane receptors whose large extracellular domains interact with adhesive molecules of the extracellular matrix, or with counterreceptors on other cells, to mediate cell adhesion. Their smaller cytoplasmic domains interact with the cytoskeleton and are also involved in signal transduction processes (Shattil and Brugge 1991; Hynes 1992) . The integrin family is very diverse (Table 1) , and although each integrin shows selectivity in the ligands it binds, there is degeneracy of two kinds. First, many integrins bind several different ligands. Second, most extracellular matrix proteins can be recognized by multiple integrins. This is diagramed for two adhesive extracellular matrix molecules (laminin and fibrinogen) in Figure 1 . Most cells express multiple integrins and are, therefore, able to interact with extracellular matrix molecules with considerable versatility. Further complexity is added by the fact that several integrin subunits can occur in alternatively spliced forms (see asterisks in Table 1 ). In the case of vertebrate integrins, this alternative splicing is only known to affect the cytoplasmic domains, where it is thought to modulate interactions with the cytoskeleton and/or signal transduction events. However, in Drosophila, at least two integrin subunits can be alternatively spliced in their extracellular domains, in regions of the molecules close to the ligand-binding and/or subunit interaction sites Present addresses: *LGME/CNRS, U184 INSERM, Facult6 de M6dicine, 67000 Strasbourg, France; tDepartment of Pathology, Cornell University School of Veterinary Medicine, Ithaca, New York 14853. (Brown et al. 1989; G. Yee et al., in prep.) . This raises the possibility that the alternative splicing may alter ligand-binding affinity or specificity.
Whereas some extracellular matrix proteins such as collagens and laminins are encoded by multigene families, alternative splicing also introduces important variations in several extracellular matrix molecules. Both fibronectin (FN) (Hynes 1990 ) and tenascin (Spring et al. 1989; Gulcher et al. 1991; Siri et al, 1991) are alternatively spliced to produce multiple isoforms. In the case of FN, one of the alternatively spliced segments includes a site for interaction with a specific integrin (Wayner et al. 1989; Mould et al. 1990 Mould et al. , 1991 . The alternative splicing of FN and the interaction of two different integrins with different sites in FN are diagramed in Figure 2 .
Given this complexity of both integrins and their ligands, it is a challenging problem to decide which integrin-matrix interactions are involved and crucial in any given biological process. The most common approach has been to use blocking antibodies or peptides (Brower and Jaffe 1989; Leptin et al. 1989; Wilcox et al. 1989; Wilcox 1990; Zusman et el. 1992 ), and we have recently used this system to investigate the functional consequences of alternative splicing ) and of mutations in the cytoplasmic domain . It would be advantageous to be able to apply genetic analyses to study the roles of integrin-matrix interactions in vertebrates, and we have initiated a program of research directed toward this aim. We have concentrated initially on FN, its alternatively spliced isoforms, and the subset of integrins that interacts with FN. We summarize here our progress to date.
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Cell Cell Table 1 ). The best characterized are as/3t, which recognizes an RGD sequence present in all isoforms of FN, and a4fl t, which recognizes a different sequence located in the alternatively spliced V25 segment of the V region. Both parts of the figure depict functional binding sites within each FN suhunit.
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RESULTS AND DISCUSSION

Distribution of FN Isoforms In Vivo
To provide context for the molecular genetic analyses that follow, we first provide a summary of descriptive studies of the expression of the different FN isoforms in vivo. As shown in Figure 2 , there are three regions of alternative splicing of the FN transcript--EIIIB, EIIIA, and V (or IlICS)--which we refer to as B, A, and V for simplicity. Nucleic acid probes and antibodies specific for each of these segments can be prepared and have been used to define the patterns of expression of the different splice forms in embryos and adult tissues and during physiological and pathological responses. A number of generalizations can be made. First, it appears that early embryos express fibronectins (B § A § V § including all three splice segments (Norton and Hynes 1987; ffrench-Constant and Hynes 1989; DeSimone et al. 1992) . This is particularly relevant in situations where extensive cell migration occurs, such as gastrulation, neural crest migration, and development of the heart (ffrench-Constant and Hynes 1988) . In all these situations, FN is thought to be important in promoting cell migration (Hynes 1990) . Second, as development of differentiated cell types proceeds, certain of the alternative segments are omitted in a celltype-specific fashion (Vartio et at. 1987; Burton-Wurster et at. 1989; ffrench-Constant and Hynes 1989; Glukhova et al. 1989 Glukhova et al. , 1990 Bennett et al. 1991; Pagani et al. 1991) ; Figure 3 diagrams a few examples. Finally, the pattern of alternative splicing can alter in response to various stimuli. Examples include wound healing (ffrench-Constant et al. 1989) , myocardial infarction Knowlton et al. 1992) , atherosclerosis (Glukhova et al. 1989 (Glukhova et al. , 1990 Mamuya and Brecher 1992) , lung injury (Peters et al. 1988) , and tumorigenesis (Carnemolla et al. 1989; Oyama et al. 1989) . In each case, there appears to be an increase in the inclusion of the B and A segments, which are frequently present at low levels at steady state in adult tissues but increase in response to the various pathological situations. One can view this response as a reversion to the pattern found in early embryos; this viewpoint highlights the fact that inclusion of the B and A segments correlates with proliferation and/or migration of cells.
Such descriptive analyses of the distribution of FN isoforms can only suggest hypotheses; they cannot test them. To do that, it is necessary to obtain the different isoforms in homogeneous form to test for differential functions or to manipulate the expression of the isoforms.
Molecular Genetic Analysis of FN lsoforms and lntegrins In Vitro
Since all or most tissues express a mixture of different FN isoforms and since cells frequently form disulfide-bonded heterodimers of different isoforms expressed within the same cell (Schwarzbauer et al. , 1989 , it is essentially impossible to purify homogeneous FN isoforms from natural sources. Even plasma FN, which lacks the B and A segments, is 50% V § 50% V- (Paul et al. 1986) , and V+/V heterodimers are the rule (Schwarzbauer et al. 1989) . Since most functional studies on FN have been performed with plasma FN, they have not addressed the functions of the B or A segments. To circumvent this limitation, we have established cell lines expressing full-length FN isoforms encoded by cDNAs . By introducing the eDNA expression constructs into cells that do not synthesize FN, we were able to produce homogeneous FNs of each defined splicing pattern. Such recombinant-derived FN isoforms can then be used to test for functions dependent on the presence of specific splice segments.
In this way, we were able to demonstrate that lymphoid cells adhere specifically only to those FN forms containing the V segment ). We were also able to show that this adhesion is mediated by the 0/4/31 integrin, which recognizes a short sequence in a part of the V segment (V25) that can be alternatively spliced as a unit . These results conform with data from other laboratories using fragments of plasma FN and synthetic peptides (Wayner et al. 1989; Mould et al. 1990 ). The lymphoid cells used lack the a5/31 integrin, which recognizes the RGD sequence present in all FNs. However, we introduced an 0/5 cDNA construct into the cells by retroviral transduction and obtained cells expressing 0/5/3t, as well as a4/31. Figure 4a shows that these cells adhere to all forms of FN, irrespective of the presence or absence of the V segment (or any other alternatively spliced segment), in marked contrast with the parent cell line, which expresses 0/4/31 but not a5/31 (Fig. 4b) . This experiment demonstrates the use by cells of different FN receptor integrins to discriminate among different FN isoforms. Similar experiments to test for specific functions conferred by the B and A segments are under way but have, so far, failed to reveal a similarly clear distinction.
Molecular Genetic Analysis of FN Isoforms and Integrins In Vivo
To extend these analyses to the in vivo situation and initiate genetic analyses of the roles of different FN isoforms and different integrin receptors for FN, we have turned to molecular genetic approaches in mice. The development of methods for producing transgenic mice (Hanahan 1989) and, more recently, for generating targeted mutations by homologous recombination in embryonic stem (ES) cells (Capecchi 1989 ) have opened the way to production of mice mutant in genes of interest.
We have used the methods of Capecchi and coworkers (Thomas and Capecchi 1987; Mansour et al. 1988 ) to generate null mutations for FN and for 0/4 and % integrin subunits. In each case, clones were isolated from mouse genomic libraries that included the 5' end of the gene. Sequencing of each of the clones located the exon encoding the translation initiation site and signal sequence. We then deleted a segment spanning the initiation codon, all or part of the signal sequence, and Y-flanking sequences. In the case of the FN gene, these included the probable site of initiation of transcription as well as parts of the promoter . It is likely that the same is true for the segments deleted from the 0/4 and 0/5 integrin clones, but these genes have not been analyzed as extensively. The deleted segment in each case was replaced by a cassette comprising the Escherichia coli neomycin-resistance gene driven by the phosphoglycerate kinase (PGK) promoter and followed by a polyadenylation site. Each of the constructs contained 750-850 bp of 5'-flanking sequence from the gene and 5-6 kbp of genomic sequence 3' of the neo r~ insertion (Fig. 5a ). In addition, at one or both ends of the construct, we inserted a second cassette comprising the herpes simplex virus thymidine kinase (TK) gene driven by the PGK promoter. The constructs were linearized and introduced into 1 x 108 to 4 x 108 D3 129/Sv ES cells (Doetschman et al. 1985) by electroporation at 25 p~g/ml of DNA. The ES cells were plated for 1 day and then subjected to selection with G418 (200/zg/ml) and gancyclovir (2 p.M) for 6-8 days. The G418 selects for cells expressing the neo R cassette, whereas the gancyclovir selects against cells expressing the TK cassette (Mansour et al. 1988 ). Doubly resistant cells should include cells in which the neo R cassette has inserted into the targeted gene by homologous recombination (Fig. 5a ). Doubly resistant clones were screened for the appropriate recombinational event by Southern blotting or by PCR and, in each case, we obtained multiple clones with the desired insertional mutation. These were further tested by Southern blotting and grown up for injection into C57BL6 blastocysts (Hogan et al. 1986 ). Male chimeras with a high level of agouti coat color (derived from the 129/Sv ES ceils) were bred with C57BL6 females and, in each case, we obtained transmission of ES cell-derived gametes. Screening of these agouti progeny by tail blotting revealed transmission of the ) and containing part of the promoter and first exon is deleted and replaced by a selectable marker, the neomycin-resistance cassette (neoR). DNA containing this replacement plus flanking sequences is fused to a counterselectable marker (TK) and transfected into ES cells. Homologous recombination with the wild-type locus inserts the neo R marker into the genome but deletes the TK marker (see text). Thus, the targeted locus is defective (since it lacks the sites for initiation of transcription and translation) and can be selected on the basis of the neo ~ insertion. Correct recombination can be confirmed by PCR analysis (arrows) and/or by Southern blotting using a probe outside the end (X) of the targeting vector. Exactly analogous strategies were used for the c~ 4 and as genes. (b) The region of the gene encoding the EIIIB segment (in a single exon) is shown. Targeting vectors lacking the EIIIB exon or containing it fused to the adjacent exons were constructed. Each construct also contained the neo R selectable marker in an adjacent intron and the counterselectable marker (TK) at one end. Insertion of these mutations into the gene can be obtained as depicted in a.
mutated alleles with approximately 50% frequency. Therefore, inactivation of the FN gene or of the a 4 or a 5 integrin genes produces recessive mutations, since the heterozygous mutant mice are viable and outwardly normal. We have therefore been able to establish heterozygous F 1 lines for each of these presumptively null mutations. All three lines have been self-intercrossed. The FN and a 5 lines have been tested by tail blotting and, in both cases, it is clear that the mutations are embryonic lethals; no homozygous mutant progeny have been observed. Progeny of the a 4 line have not been tested as yet. These data clearly demonstrate the importance of FN and a~/3~ integrin for completion of embryonic development.
Analysis of embryonic lethal mutations requires sampling of embryos and/or fetuses at different stages of development. The embryos can then be examined, sectioned for histological and immunohistochemical analyses, and used to derive cultures for biochemical and cell biological analyses. By the latter procedures, we have confirmed that both the FN and u5 mutations are true null mutations and that the respective proteins are not produced by homozygous mutant embryos. The morphological, histological, and immunohistological analyses are most advanced for the FN mutant embryos; some of the results are illustrated briefly here.
FN is first observed in the preimplantation blastocyst (Zetter and Martin 1978; R.O. Hynes et al., unpubl.) but is expressed at higher levels in postimplantation stages. Figure 6a illustrates a day-7.5 embryo at the primitive streak stage stained for FN. FN is concentrated at the interfaces between the three germ layers and is also present within the mesodermal layer, in agreement with published data (Wartiovaara et al. 1979 ). In contrast, day-7.5 embryos that are homozygous for the FN-null mutation express no detectable FN (Fig. 6b) . However, it is of interest to note that the mutant embryo does contain three germ layers. That is, mesoderm forms in the absence of FN expression. This result contrasts with the result obtained in amphibian embryos injected with anti-FN antibodies (Boucaut et al. 1984) . In such treated amphibian embryos, mesoderm fails to migrate into the blastocoel cavity. The ectoderm continues to expand but does not invaginate, and no mesoderm forms. However, when the equivalent antibody-blocking experiment is performed in avian embryos, mesoderm does enter from the primitive streak into the underlying space, although it does not migrate laterally (Harrisson et al. 1992 ). It appears that the result in the FN-null mouse embryo parallels that in the chicken embryo treated with anti-FN antibodies; "mesoderm" forms by delamination from the ectoderm at the primitive streak. Thus, FN is not required for delamination, a process presumably involving reduction in cell-cell adhesion. We are currently analyzing whether or not mesodermal migration is defective in the mutant embryos. Furthermore, in both these cases (mouse and chicken), it is unclear whether the cells that delaminate are true mesoderm. In each case, they are defined by position only, not by expression of particular mesodermal markers. Work is in progress to investigate this issue.
FN-null mouse embryos thus initiate the process of gastrulation in the absence of FN. However, from that point on they become progressively abnormal and are resorbed by day 10-11. Some folding of epithelial sheets occurs, but the embryos are disorganized and many structures fail to form normally, clearly indicating a requirement for FN in morphogenetic processes. Fur- ther analysis of these embryos will provide further insights into the functions of FN during early development. The parallel analysis of the a 5 mutants will similarly define the functions of this integrin subunit.
Although the FN mutants clearly show the importance of FN for development, they provide no information about differential roles for the different isoforms. To address this issue, we have initiated two sets of experiments. In the first, we are attempting to generate more subtle mutations in the FN gene, which are intended to alter the pattern of splicing. In the second approach, we are attempting to generate lines of mice expressing FN transgenes of defined splicing pattern; the aim is to breed these transgenic lines with the FN-null line to ascertain which isoforms of FN can rescue the FN-null mutant phenotype and to what degree.
Both approaches have progressed to some extent, although neither is yet complete. Figure 5b illustrates one approach to the generation of FN mutations altered in splicing of the B segment, which lies in the center of the 70-kb FN gene. Two mutant constructs were made, one lacking the exon encoding the B segment and one in which a three-exon/two-intron segment of the gene was replaced by the equivalent segment of cDNA. Each construct also contained a neo R cassette in an intron and a TK cassette at one end (Fig.  5b) . ES cell clones with each of these mutations were obtained as described above, and chimeras were derived. Germ-line transmission was obtained in each case, and both heterozygous mutant lines were viable. However, in each case, homozygosity resulted in embryonic lethality, Abnormalities developed at about the same time as in the case of FN-null homozygotes, and immunohistochemical analyses indicated that little if any assembled FN was present in these embryos. These data raise the question of whether these mutations in the EIIIB region of the gene lead to more severe defects in FN expression than does simply altering the pattern of splicing, This is now under study. If these replacement constructs prove to be inadequate, an alternative approach will be to use the so-called "hit and run" method (Hasty et al. 1991) , which involves insertion of a mutation and subsequent deletion of the adja- Figure 7 . FN hybrid transgenes. Defined splicing patterns are listed below the rat cDNA portion of the transgene (stippled box). The first exon of the mouse FN gene is depicted by a white box. Fusion between mouse and rat sequences is in the first intron, depicted by a slanted line. Mice harboring these transgenes will first be analyzed for dominant effects of the transgene. Second, breeding with FN-null mutation mice will determine which FN splice variants are able to rescue the FN-null embryonic lethal phenotype. cent wild-type segment. This technique has the potential advantage that no neo R cassette is left in the mutated allele.
The transgenic approach we have used is to introduce a hybrid transgene comprising 11 kb of mouse FN promoter and 5'-flanking region fused within the first intron to a rat FN cDNA of defined splicing pattern (Fig. 7) . Seven founder lines have been generated and are being tested for expression of rat FN. If these lines produce sufficient FN, they will be intercrossed with the FN-null mice to test for rescue of the embryonic lethality. Since the FN gene is so large ( ~ 70 kb, -50 introns), we have omitted most of the introns. This may compromise expression. If the current FN transgenic lines prove inadequate, it will probably be necessary to include more of the introns and, perhaps, more flanking DNA.
CONCLUSIONS
Cell-matrix adhesion is complex, involving as it does multiple receptors and multiple ligands, both of which can sometimes undergo alternative splicing to generate isoforms that likely perform different functions. Genetic analyses represent one of the best available approaches to elucidation of the contributions of specific receptors or ligands to given functions in vivo. Such studies have been initiated in insects, where the genetics are relatively tractable. However, many of the roles of cell-matrix adhesion arise in important physiological and pathological processes such as hemostasis, thrombosis, inflammation, wound healing, and cancer, which need to be studied in mammalian systems. The development of methods for introducing genes and defined mutations in mice opens the way to analyses of cell-matrix adhesion by molecular genetics in a mammalian system. We have initiated such an approach to study the functions of FN and integrins that bind to it. The early results indicate that these molecules are indeed crucial for embryonic development ( Table 2 ). The defects occurring in the mutants are beginning to provide further information about the roles of these molecules, and further analyses using transgenes and more subtle mutations should extend these studies further.
